AMYRIS REPORTS Q1 2023 REVENUE

EMERYVILLE, Calif., April 24, 2023 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, provided an update on…


ADVERTISEMENT — Advertise With Biotech Networks